Vitamin pills increase mortality

Denmark - Vitamins A, E and beta carotene, taken singly or with other supplements, 'significantly increase mortality' according to a review study released by the Cochrane Hepato-Biliary Group* at Copenhagen University Hospital. Their study, published in the Journal of the American Medical Association (JAMA), did not find evidence that vitamin C could increase longevity, but did find that selenium tended to reduce the risk of death.

The Copenhagen researchers analysed 68 previous trials of the five antioxidant supplements, involving 232,606 participants, and say their findings contradict those of observational studies that claim antioxidants improve health. ‘Considering that 10-20% of the adult population (80-160 million people) in North America and Europe may consume the assessed supplements, the public health consequences may be substantial.’

The team reported that 47 ‘low-bias risk’ trials, with 180,938 participants, were ‘best quality’. Based on those low-bias studies, vitamin supplements were found to be associated with a 5% increased risk of mortality. Beta carotene was associated with a 7% risk, vitamin A with a 16% risk and vitamin E with a 4% risk. No increased mortality risk with vitamin C or selenium were seen.

* The Cochrane is an international network of experts who carry out systematic reviews of scientific evidence on health interventions.

08.03.2007

More on the subject:

Related articles

Photo

News • Multi-lens ultrasound arrays

4D blood flow imaging of whole organs

3D + time: a new 4D ultrasound imaging technique could both improve our understanding of the circulatory system and facilitate the diagnosis of certain blood circulation-related diseases.

Photo

News • Selective degradation of neurons

ALS: Key mechanism behind motor function loss discovered

Why does amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, attack motor neurons, the cells that control body movement, while others are spared? A new study may have found an answer.

Photo

News • Orthopedic ultrasound screening

AI helps spot signs of dysplasia in infant hips

Developmental dysplasia of the hip occurs in 2-4% of infants, but screening via ultrasound is notoriously hard to master. An AI-assisted application could prevent many unnecessary hospital referrals.

Related products

Subscribe to Newsletter